Growth Metrics

Sarepta Therapeutics (SRPT) EBT (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 223.31%
Dec 31, 2025 -43.42%
Sep 30, 2025 -226.30%
Jun 30, 2025 140.06%
Mar 31, 2025 -581.59%
Dec 31, 2024 134.18%
Sep 30, 2024 150.47%
Jun 30, 2024 -67.24%
Mar 31, 2024 -85.15%
Dec 31, 2023 941.11%
Sep 30, 2023 -127.45%
Jun 30, 2023 97.16%
Mar 31, 2023 -252.02%
Dec 31, 2022 231.53%
Sep 30, 2022 -12.42%
Jun 30, 2022 -119.01%
Mar 31, 2022 -40.25%
Dec 31, 2021 -55.00%
Sep 30, 2021 41.40%
Jun 30, 2021 51.16%
Mar 31, 2021 11.19%
Dec 31, 2020 4.03%
Sep 30, 2020 -30.24%
Jun 30, 2020 -767.81%
Mar 31, 2020 92.61%
Dec 31, 2019 -86.35%
Sep 30, 2019 54.35%
Jun 30, 2019 -260.81%
Mar 31, 2019 45.96%
Dec 31, 2018 -83.83%
Sep 30, 2018 29.07%
Jun 30, 2018 -208.44%
Mar 31, 2018 -36.32%
Dec 31, 2017 43.49%
Sep 30, 2017 27.60%
Jun 30, 2017 -173.36%
Mar 31, 2017 197.33%
Dec 31, 2016 -55.88%
Sep 30, 2016 8.92%
Jun 30, 2016 -4.23%
Mar 31, 2016 7.26%
Dec 31, 2015 -24.51%
Sep 30, 2015 -22.93%
Jun 30, 2015 31.93%
Mar 31, 2015 -38.33%
Dec 31, 2014 -32.80%
Sep 30, 2014 -11.25%
Jun 30, 2014 -20.50%
Mar 31, 2014 23.53%
Dec 31, 2013 -32.08%
Sep 30, 2013 -45.39%
Jun 30, 2013 -12.70%
Mar 31, 2013 -47.60%
Dec 31, 2012 -50.38%
Sep 30, 2012 -25.47%
Jun 30, 2012 19.59%
Mar 31, 2012 23.44%
Dec 31, 2011 20.04%
Sep 30, 2011 -11.01%
Jun 30, 2011 -83.31%
Mar 31, 2011 -229.56%
Dec 31, 2010 55.56%
Sep 30, 2010 51.22%